Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Assets (2019 - 2025)

Historic Assets for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $105.2 million.

  • Benitec Biopharma's Assets rose 60144.01% to $105.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $105.2 million, marking a year-over-year increase of 60144.01%. This contributed to the annual value of $52.2 million for FY2024, which is 106957.89% up from last year.
  • As of Q1 2025, Benitec Biopharma's Assets stood at $105.2 million, which was up 60144.01% from $79.1 million recorded in Q4 2024.
  • Over the past 5 years, Benitec Biopharma's Assets peaked at $105.2 million during Q1 2025, and registered a low of $4.5 million during Q2 2023.
  • Over the past 5 years, Benitec Biopharma's median Assets value was $17.8 million (recorded in 2021), while the average stood at $29.1 million.
  • Per our database at Business Quant, Benitec Biopharma's Assets tumbled by 7206.14% in 2022 and then skyrocketed by 106957.89% in 2024.
  • Over the past 5 years, Benitec Biopharma's Assets (Quarter) stood at $14.0 million in 2021, then dropped by 15.05% to $11.9 million in 2022, then surged by 79.36% to $21.4 million in 2023, then soared by 270.29% to $79.1 million in 2024, then soared by 33.06% to $105.2 million in 2025.
  • Its Assets was $105.2 million in Q1 2025, compared to $79.1 million in Q4 2024 and $68.8 million in Q3 2024.